Caribou Biosciences appoints Sri Ryali as CFO, effective January 2, 2025

Caribou Biosciences, Inc.

Sri Ryali named CFO; brings 20 years biopharma finance experience; most recently CFO of Codexis.
Ryan Fischesser ceases as interim principal financial officer and accounting officer; remains VP Finance.
Ryali receives $485k base salary, 40% target bonus, and option to purchase 300k shares vesting over 4 years.
Company highlights four clinical-stage programs for hematologic malignancies and autoimmune diseases; expects multiple datasets in 2025.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sriram Ryali

Chief Financial Officer

CRBU · Caribou Biosciences, Inc.

Effective: 2025-01-02
Filed: January 2, 2025, 6:59 PM ET

On January 2, 2025, Caribou Biosciences, Inc., a Delaware corporation (the “Company”), announced the appointment of Sriram Ryali, age 44, to the position of Chief Financial Officer (“CFO”) of the Company, effective as of January 2, 2025 (the “Start Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sriram Ryali was appointed as Chief Financial Officer at Caribou Biosciences, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On January 2, 2025, Caribou Biosciences, Inc., a Delaware corporation (the “Company”), announced the appointment of Sriram Ryali, age 44, to the position of Chief Financial Officer (“CFO”) of the Company, effective as of January 2, 2025 (the “Start Date”).

View on SEC.gov

Caribou Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001619856-25-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.